United States: Industry Fights Back Against Government Restrictions On Pharmaceutical Manufacturers' Ability To Offer Drug Cost-Sharing Subsidies - Sheppard Mullin Richter & Hampton

This year, the Office of Inspector General ("OIG") and at least two federal courts have taken a clear stance against pharmaceutical manufacturers' attempts to offer cost-sharing subsidies...